Aurora Cannabis (ACB) Return on Equity (2025)

Aurora Cannabis (ACB) reported Return on Equity of 0.0% for Q4 2025, down 121.62% quarter-over-quarter from 0.0% in Q3 2025.

Aurora Cannabis (ACB) Return on Equity (2025) Analysis & Trends

Aurora Cannabis (ACB) has 1 years of Return on Equity data on file, last reported at 0.0% in Q4 2025.

Return on Equity for Q4 2025 came in at 0.0%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed N/A YoY), and the FY2025 annual result was 0.0%, changed N/A from the prior year.
Return on Equity declined to 0.0% in Q4 2025 per ACB's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Equity peaked at 0.0% in Q3 2025 and troughed at 0.0% in Q2 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROE (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	0.00%
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	0.01%
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	0.00%
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	0.00%
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	0.00%
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	0.00%
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	0.00%
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	0.00%
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	0.00%
10	Liquidia	5.63 Bn	5.40 Bn	121.79 Mn	0.00%

Historic Data

Download Data

Date	Value
Dec 31, 2025	0.00%
Sep 30, 2025	0.00%
Jun 30, 2025	0.00%